Henan Provincial Eye Hospital

Running trials

• Not yet recruiting

  To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

  NCT07406438· Phase 1· Shenzhen Kexing Pharmaceutical Co., Ltd.· Source

• Recruiting

  Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

  NCT07515079· Phase 3· Bio-Thera Solutions· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease1 recruiting
• Macular degeneration1 recruiting

Closed trials

• Completed

  A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema

  NCT06422507· Phase 3· Bayer· Source

• Completed

  A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

  NCT05520177· Phase 3· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.· Source

• Completed

  Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema

  NCT04772105· Phase 1/2· Bio-Thera Solutions· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Bayer· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Retinitis pigmentosa6 works · 0 trials